X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

5 Workplace Discrimination Examples Based on Immigration Status and National Origin

Last month, the New York City Commission on Human Rights (“NYCCHR”) adopted enforcement guidance o...

Read More >

Georgia Court of Appeals upholds arbitration award applying Cardinal Change Theory

In Gainesville Mechanical, Inc. v. Air Data, Inc., --- S.E.2d ---- (June 19, 2019), the Georgia Cour...

Read More >

ACA Employer Mandate Reporting Deadline Extended

Continuing a welcome holiday tradition, the Internal Revenue Service has given applicable large empl...

Read More >

New Jersey Closes all Non-Essential Construction Projects

On April 8, 2020, New Jersey Governor Phil Murphy signed Executive Order No. 122, requiring the clos...

Read More >

Supreme Court: Title VII’s Requirements Not Jurisdictional

In a unanimous decision, the U.S. Supreme Court ruled that Title VII’s charge-filing precondition t...

Read More >

Beware of the “Overshare”: Construe Requests for ERISA Plan Documents Narrowly!

Seyfarth Synopsis: Administrators of ERISA plans frequently receive requests from participants, ben...

Read More >